kirk campbell, md

Kirk Campbell, MD, is the Irene and Dr. Arthur Fishberg Professor of Medicine at the Icahn School of Medicine at Mount Sinai. He is a graduate of the University of Connecticut School of Medicine and completed residency training in Internal Medicine at Yale-New Haven Hospital. He completed a clinical nephrology fellowship and advanced research training in podocyte cell biology and experimental glomerular disease at Mount Sinai. In addition to treating patients with kidney disease, Dr. Campbell leads an NIH-funded research program focused on developing new therapeutic interventions for proteinuric diseases. He actively participates in clinical trials testing novel agents for primary glomerular disease and is an elected member of the American Society for Clinical Investigation. He is a Past-President of the New York Society of Nephrology, a member of the Board of Directors of the Nephcure Foundation, a standing member of the Pathobiology of Kidney Disease (PBKD) study section at the National Institutes of Health, the Medical Advisory Board of the National Kidney Foundation of Greater New York. He has served on the American Society of Nephrology Grants Review and Kidney Week Education Committees.

Jenny Wong, Ph.D.

Jenny Wong, Ph.D. is an Assistant Professor at the Icahn School of Medicine at Mount Sinai. She received her undergraduate degree at Harvard College and her Ph.D. degree in Biomedical Sciences from the Icahn School of Medicine under the mentorship of Peter Mundel.  Her thesis project published in the EMBO Journal, identified novel mechanisms for RhoA stabilization in the regulation of actin fiber dynamics and cell motility. She has more than 17 years experience in mammalian cell culture, imaging, cell signaling, molecular biology, protein biochemistry and experimental models of glomerular disease as well as differentiating induced pluripotent stem cells into podocytes and kidney organoids.

Jenny Wong PhD

Kristin Meliambro, MD

Kristin Meliambro, MD, is an Assistant Professor of Medicine/Nephrology at the Icahn School of Medicine at Mount Sinai. She is a graduate of the Icahn School of Medicine at Mount Sinai, and completed both her Internal Medicine residency and clinical Nephrology fellowship at Mount Sinai Hospital. She subsequently joined the Campbell lab for a basic research fellowship investigating the role of the Hippo signaling pathway in podocyte injury and glomerular disease. Her research is currently funded by a K08 Award from the NIDDK and utilizes cell-based, murine models and clinical samples to define mediators od glomerular disease progression. She is also the co-Director of the Division of Nephrology’s Biorepository and actively participates in clinical trials on novel therapeutic agents for diseases such as focal segmental glomerulosclerosis (FSGS), IgA nephropathy, diabetic nephropathy, and membranous nephropathy.